These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2484323)

  • 1. New anticancer agents.
    Weiss GR; Arteaga CL; Brown TD; Craig JB; Harman GS; Havlin KA; Koeller JM; Kuhn JG; Von Hoff DD
    Cancer Chemother Biol Response Modif; 1988; 10():85-116. PubMed ID: 2484323
    [No Abstract]   [Full Text] [Related]  

  • 2. New anticancer agents.
    Brown TD; Burris HA; Havlin KA; O'Rourke TJ; Rodriguez GI; Wall JG; Weiss GR
    Cancer Chemother Biol Response Modif; 1991; 12():111-46. PubMed ID: 1718374
    [No Abstract]   [Full Text] [Related]  

  • 3. New anticancer agents.
    Weiss GR; Arteaga CL; Brown TD; Craig JB; Harman GS; Koeller JM; Kuhn JG; Von Hoff DD
    Cancer Chemother Biol Response Modif; 1987; 9():93-120. PubMed ID: 2484330
    [No Abstract]   [Full Text] [Related]  

  • 4. Anthracycline analogs: the past, present, and future.
    Weiss RB; Sarosy G; Clagett-Carr K; Russo M; Leyland-Jones B
    Cancer Chemother Pharmacol; 1986; 18(3):185-97. PubMed ID: 2948729
    [No Abstract]   [Full Text] [Related]  

  • 5. New anthracycline antitumor antibiotics.
    Muggia FM; Green MD
    Crit Rev Oncol Hematol; 1991; 11(1):43-64. PubMed ID: 1831987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel chemotherapeutic agents in early clinical development.
    Stagg MP; Diasio RB
    Curr Opin Oncol; 1990 Dec; 2(6):1119-25. PubMed ID: 1983089
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer.
    Boven E; Schlüper HM; Erkelens CA; Pinedo HM
    Eur J Cancer; 1990; 26(9):983-6. PubMed ID: 2149026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine nucleoside analogs in indolent non-Hodgkin's lymphoma.
    Cabanillas F
    Oncology (Williston Park); 2000 Jun; 14(6 Suppl 2):13-5. PubMed ID: 10887639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS
    Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433
    [No Abstract]   [Full Text] [Related]  

  • 11. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 13. The biochemical pharmacology of nogalamycin and its derivatives.
    Li LH; Krueger WC
    Pharmacol Ther; 1991; 51(2):239-55. PubMed ID: 1838416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study.
    Vance RB; Crowley JJ; Macdonald JS; Ahmann FR
    Invest New Drugs; 1991 Feb; 9(1):73-5. PubMed ID: 1851143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
    Sternberg CN; Sordillo PP; Cheng E; Chuang YJ; Niedzwiecki D
    Am J Clin Oncol; 1987 Jun; 10(3):219-21. PubMed ID: 2884864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of menogaril in advanced colorectal cancer.
    Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM
    Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure.
    Buckner JC; Edmonson JH; Ingle JN; Schaid DJ
    Am J Clin Oncol; 1989 Oct; 12(5):384-6. PubMed ID: 2529759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menogaril in the treatment of malignant mesothelioma: a phase II study.
    Hudis CA; Kelsen DP
    Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.